Alpha 2.0
Login Register
» Authors » Bernadette Abela

Bernadette Abela

Explore the profile of Bernadette Abela including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 268
Followers 0
Related Specialties
General Medicine
Public Health
Infectious Diseases
Top 10 Co-Authors
Valerie Courgnaud
Eric Delaporte
Martine Peeters
Eitel Mpoudi-Ngole
Xavier Pourrut
Severin Loul
Katrin Bote
Deborah Nadal
Florian Liegeois
Frederic Bibollet-Ruche
Published In
J Virol
Lancet
Emerg Infect Dis
Lancet Glob Health
IJID One Health
Affiliations
Soon will be listed here.
Recent Articles
1.
Accelerating rabies elimination in Africa by 2030
Amani A, Abela B, Biey J, Traore T, Impouma B
Lancet . 2024 Sep; PMID: 39348831
No abstract available.
2.
Climate change, malaria and neglected tropical diseases: a scoping review
Klepac P, Hsieh J, Ducker C, Assoum M, Booth M, Byrne I, et al.
Trans R Soc Trop Med Hyg . 2024 May; 118(9):561-579. PMID: 38724044
To explore the effects of climate change on malaria and 20 neglected tropical diseases (NTDs), and potential effect amelioration through mitigation and adaptation, we searched for papers published from January...
3.
Rabies post-exposure prophylaxis delivery to ensure treatment efficacy and increase compliance
Nadal D, Bote K, Masthi R, Narayana A, Ross Y, Wallace R, et al.
IJID One Health . 2023 Dec; 1:100006. PMID: 38152594
Objectives: Since rabies is lethal once symptoms appear, its prevention including community awareness, mass dog vaccination and post-exposure prophylaxis (PEP) is crucial. Although safe and potent rabies vaccines have long...
4.
Is there hope to reach the Zero by 30 target for dog-mediated human rabies?
Nadal D, Bote K, Abela B
Lancet Glob Health . 2023 Sep; 11(11):e1682-e1683. PMID: 37776869
No abstract available.
5.
A call to accelerate an end to human rabies deaths
Thumbi S, Blumberg L, le Roux K, Salahuddin N, Abela B
Lancet . 2022 Dec; 400(10369):2261-2264. PMID: 36528379
No abstract available.
6.
Simian T-cell leukemia virus (STLV) infection in wild primate populations in Cameroon: evidence for dual STLV type 1 and type 3 infection in agile mangabeys (Cercocebus agilis)
Courgnaud V, Van Dooren S, Liegeois F, Pourrut X, Abela B, Loul S, et al.
J Virol . 2004 Apr; 78(9):4700-9. PMID: 15078952
Three types of human T-cell leukemia virus (HTLV)-simian T-cell leukemia virus (STLV) (collectively called primate T-cell leukemia viruses [PTLVs]) have been characterized, with evidence for zoonotic origin from primates for...
7.
Identification of a new simian immunodeficiency virus lineage with a vpu gene present among different cercopithecus monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon
Courgnaud V, Abela B, Pourrut X, Mpoudi-Ngole E, Loul S, Delaporte E, et al.
J Virol . 2003 Nov; 77(23):12523-34. PMID: 14610175
During a large serosurvey of wild-caught primates from Cameroon, we found 2 mona monkeys (Cercopithecus mona) out of 8 and 47 mustached monkeys (Cercopithecus cephus) out of 302 with human...
8.
Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny
Courgnaud V, Salemi M, Pourrut X, Mpoudi-Ngole E, Abela B, Auzel P, et al.
J Virol . 2002 Jul; 76(16):8298-309. PMID: 12134035
In the present study, we describe a new simian immunodeficiency virus (SIV), designated SIVgsn, naturally infecting greater spot-nosed monkeys (Cercopithecus nictitans) in Cameroon. Together with SIVsyk, SIVgsn represents the second...
9.
Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat
Peeters M, Courgnaud V, Abela B, Auzel P, Pourrut X, Bibollet-Ruche F, et al.
Emerg Infect Dis . 2002 May; 8(5):451-7. PMID: 11996677
To assess human exposure to Simian immunodeficiency virus (SIV) in west central Africa, we looked for SIV infection in 788 monkeys that were hunted in the rainforests of Cameroon for...